Advertisement
UK markets close in 4 hours 24 minutes
  • FTSE 100

    8,117.49
    +38.63 (+0.48%)
     
  • FTSE 250

    19,828.23
    +226.25 (+1.15%)
     
  • AIM

    755.42
    +2.30 (+0.31%)
     
  • GBP/EUR

    1.1662
    +0.0006 (+0.05%)
     
  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     
  • Bitcoin GBP

    51,240.37
    +513.74 (+1.01%)
     
  • CMC Crypto 200

    1,385.22
    -11.31 (-0.81%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.10
    +0.53 (+0.63%)
     
  • GOLD FUTURES

    2,360.20
    +17.70 (+0.76%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,049.13
    +131.85 (+0.74%)
     
  • CAC 40

    8,040.53
    +23.88 (+0.30%)
     

Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript

Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript

With me as usual are Kevin Gorman, our chief executive officer; Matt Abernethy, our chief financial officer; Eiry Roberts, our chief medical officer; Eric Benevich, our chief commercial officer; and Kyle Gano, our chief business development and strategy officer. Before we get going, I'll remind everyone that during today's call, we will be making forward-looking statements.